Spago Nanomedical AB (publ) (STO:SPAGO)
0.1100
0.00 (0.00%)
Jun 11, 2026, 5:14 PM CET
Spago Nanomedical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25.92 | 29.67 | 32.47 | 45.22 | 62.1 | 52.46 |
Cash & Short-Term Investments | 25.92 | 29.67 | 32.47 | 45.22 | 62.1 | 52.46 |
Cash Growth | -2.46% | -8.62% | -28.19% | -27.19% | 18.38% | 84.41% |
Accounts Receivable | 0.01 | - | 0.2 | 0.37 | 0.05 | 0.04 |
Other Receivables | 0.17 | 4.95 | 4.46 | 3.58 | 0.66 | 0.86 |
Receivables | 0.18 | 4.95 | 4.66 | 3.95 | 0.71 | 0.89 |
Prepaid Expenses | 2.58 | 1.32 | 1.46 | 2.74 | 2.43 | 1.03 |
Other Current Assets | 0.87 | - | -0 | -0 | - | - |
Total Current Assets | 29.55 | 35.94 | 38.59 | 51.91 | 65.24 | 54.39 |
Property, Plant & Equipment | 0.12 | 0.14 | 0.61 | 0.93 | 0.85 | 1.08 |
Long-Term Investments | - | - | - | - | 0 | - |
Other Intangible Assets | - | - | - | - | 8.11 | 7.31 |
Long-Term Deferred Charges | - | - | - | - | 131.74 | 128.85 |
Other Long-Term Assets | 0.67 | 0.61 | 0.38 | 0.15 | -0 | - |
Total Assets | 30.34 | 36.68 | 39.58 | 52.99 | 205.95 | 191.62 |
Accounts Payable | 2.78 | 3.16 | 2.72 | 6.39 | 4.73 | 3.86 |
Accrued Expenses | 2.2 | 1.15 | 1.82 | 1.53 | 1.56 | 1.49 |
Other Current Liabilities | 0.32 | 0.85 | 1.32 | 3.56 | 2.51 | 1.47 |
Total Current Liabilities | 5.3 | 5.17 | 5.86 | 11.48 | 8.8 | 6.81 |
Pension & Post-Retirement Benefits | 0.67 | 0.61 | 0.38 | 0.15 | - | - |
Other Long-Term Liabilities | 0.17 | 0.16 | 0.1 | 0.04 | - | - |
Total Liabilities | 6.14 | 5.94 | 6.35 | 11.67 | 8.8 | 6.81 |
Common Stock | 6.62 | 6.62 | 3.48 | 18.86 | 90.94 | 41.18 |
Additional Paid-In Capital | 303.4 | 303.4 | 282.1 | 270.56 | 257.15 | 255.37 |
Retained Earnings | - | - | - | - | -150.93 | -111.74 |
Comprehensive Income & Other | -285.82 | -279.27 | -252.35 | -248.1 | - | - |
Total Common Equity | 24.2 | 30.75 | 33.24 | 41.32 | 197.16 | 184.81 |
Shareholders' Equity | 24.2 | 30.75 | 33.24 | 41.32 | 197.16 | 184.81 |
Total Liabilities & Equity | 30.34 | 36.68 | 39.58 | 52.99 | 205.95 | 191.62 |
Net Cash (Debt) | 25.92 | 29.67 | 32.47 | 45.22 | 62.1 | 52.46 |
Net Cash Growth | -2.46% | -8.62% | -28.19% | -27.19% | 18.38% | 84.41% |
Net Cash Per Share | 0.06 | 0.08 | 0.09 | 0.46 | 0.97 | 1.33 |
Filing Date Shares Outstanding | 661.57 | 661.57 | 348.2 | 219.51 | 90.94 | 41.18 |
Total Common Shares Outstanding | 661.57 | 661.57 | 348.2 | 219.51 | 90.94 | 41.18 |
Working Capital | 24.25 | 30.77 | 32.72 | 40.43 | 56.45 | 47.58 |
Book Value Per Share | 0.04 | 0.05 | 0.10 | 0.19 | 2.17 | 4.49 |
Tangible Book Value | 24.2 | 30.75 | 33.24 | 41.32 | 189.04 | 177.5 |
Tangible Book Value Per Share | 0.04 | 0.05 | 0.10 | 0.19 | 2.08 | 4.31 |
Machinery | - | 1.44 | 4.27 | 4.8 | 4.45 | 4.31 |